Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > One more . . :-)

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Mar 18, 2021 1:00pm

190 Views

Post# 32826704

RE:RE:RE:RE:RE:RE:RE:RE:RE:One more . . :-)

Trending upward on no news? Maybe for the week (for now) but hardly a trend. It was likely "trending up" for this conference where people may have expected news prior to it starting.

Map SVA chart over the CDNX chart and you'll see that the price has more to do with the general market sentiment than it does what the company is doing.

I will continue to sell into strength and so will everyone else until the company announces something worthy of holding. Not saying I won't buy the shares back lower.

You seem to be bothered when I sell some of my shares. Didn't you liquidate your entire holding and then buy back a few days later at a higher price than what you sold for? No one complained about it. I am still long but I will continue to play the swings when appropriate and carefully monitor the markets in general. They will dictate the shareprice until the company puts out meaningful news.